GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (FRA:640) » Definitions » Margin of Safety % (DCF Earnings Based)

China Resources Pharmaceutical Group (FRA:640) Margin of Safety % (DCF Earnings Based) : 59.40% (As of Jul. 02, 2025)


View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2025-07-02), China Resources Pharmaceutical Group's Predictability Rank is 4-Stars. China Resources Pharmaceutical Group's intrinsic value calculated from the Discounted Earnings model is €1.33 and current share price is €0.54. Consequently,

China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 59.40%.


Competitive Comparison of China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based)

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based) falls into.


;
;

China Resources Pharmaceutical Group Margin of Safety % (DCF Earnings Based) Calculation

China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(1.33-0.54)/1.33
=59.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.


China Resources Pharmaceutical Group Margin of Safety % (DCF Earnings Based) Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
26 Harbour Road, Room 4104-05, 41st Floor, China Resources Building, Wanchai, HKG
China Resources Pharmaceutical is the third-largest medical distributor in China by revenue. It is an integrated pharmaceutical company specializing in research and development, manufacturing, medical distribution, and retail pharmacies. As of 2024, the medical distribution business accounts for 82.8% of its total revenue. CR Pharma's manufacturing business, 18.0% of total revenue, has subsidiaries with a strong presence in traditional Chinese medicine and consumer healthcare.

China Resources Pharmaceutical Group Headlines

No Headlines